Alembic Pharmaceuticals (BOM:533573) COGS-to-Revenue : 0.25 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals COGS-to-Revenue?

Alembic Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹3,794 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹15,170 Mil.

Alembic Pharmaceuticals's COGS to Revenue for the three months ended in Mar. 2024 was 0.25.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Alembic Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2024 was 74.99%.

Alembic Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Alembic Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals COGS-to-Revenue Chart

Alembic Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

COGS-to-Revenue

Get a 7-Day Free Trial

0.29

0.33

0.30

0.28

Alembic Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.31	0.28	0.29	0.28	0.25

Alembic Pharmaceuticals COGS-to-Revenue Calculation

Alembic Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17150.8	/	62286.3
	=	0.28

Alembic Pharmaceuticals's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3793.6	/	15169.8
	=	0.25

Alembic Pharmaceuticals (BOM:533573) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Alembic Pharmaceuticals's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	3793.6 / 15169.8
	=	74.99 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Alembic Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alembic Pharmaceuticals (BOM:533573) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

APLLTD:India

Address

Alembic Road, Vadodara, GJ, IND, 390 003

Website

https://www.alembicpharmaceuticals.com

Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines